NL301235I2 - abaloparatide - Google Patents

abaloparatide

Info

Publication number: NL301235I2
Authority: NL; Netherlands
Prior art keywords: abaloparatide
Prior art date: 2006-10-03

Application number

NL301235C

Other languages

English (en)

Original Assignee

Ipsen Pharma Sas

Radius Health Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-03

Filing date

2023-06-09

Publication date

2023-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39430237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL301235(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2023-06-09 Application filed by Ipsen Pharma Sas, Radius Health Inc filed Critical Ipsen Pharma Sas

2023-08-31 Publication of NL301235I2 publication Critical patent/NL301235I2/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Compositions Of Macromolecular Compounds (AREA)
Materials For Medical Uses (AREA)

NL301235C 2006-10-03 2023-06-09 abaloparatide NL301235I2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84896006P	2006-10-03	2006-10-03
PCT/US2007/021216 WO2008063279A2 (en)	2006-10-03	2007-10-03	A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof

Publications (1)

Publication Number	Publication Date
NL301235I2 true NL301235I2 (nl)	2023-08-31

Family

ID=39430237

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL301235C NL301235I2 (nl)	2006-10-03	2023-06-09	abaloparatide

Country Status (28)

Country	Link
US (1)	US8148333B2 (nl)
EP (2)	EP2957278B1 (nl)
JP (1)	JP5375611B2 (nl)
KR (4)	KR20180117738A (nl)
CN (2)	CN102274492B (nl)
AU (1)	AU2007322334B2 (nl)
BR (2)	BRPI0719821B8 (nl)
CA (1)	CA2664734C (nl)
CY (1)	CY1119198T1 (nl)
DK (2)	DK2073789T3 (nl)
ES (2)	ES2637283T3 (nl)
FR (1)	FR23C1024I2 (nl)
HR (1)	HRP20171217T1 (nl)
IL (1)	IL197926A (nl)
LT (1)	LT2957278T (nl)
LU (1)	LUC00309I2 (nl)
MX (1)	MX2009003569A (nl)
NL (1)	NL301235I2 (nl)
NO (1)	NO344885B1 (nl)
NZ (1)	NZ576682A (nl)
PL (1)	PL2957278T3 (nl)
PT (2)	PT2957278T (nl)
RS (1)	RS56164B1 (nl)
RU (1)	RU2506070C2 (nl)
SG (1)	SG175580A1 (nl)
SI (1)	SI2957278T1 (nl)
UA (1)	UA98776C2 (nl)
WO (1)	WO2008063279A2 (nl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7803770B2 (en) *	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en)	2006-10-03	2023-03-07	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
DK2073789T3 (da)	2006-10-03	2019-08-05	Radius Health Inc	Stabil sammensætning omfattende et knogle-anabolisk protein, nemlig en pthrp-analog, og anvendelser deraf
CA2799183A1 (en)	2010-05-12	2011-11-17	Radius Health, Inc.	Therapeutic regimens
US9133182B2 (en)	2010-09-28	2015-09-15	Radius Health, Inc.	Selective androgen receptor modulators
EP2472329B1 (en)	2010-12-31	2013-06-05	Rohm and Haas Electronic Materials LLC	Coating compositions for use with an overcoated photoresist
EP2472328B1 (en)	2010-12-31	2013-06-19	Rohm and Haas Electronic Materials LLC	Coating compositions for use with an overcoated photoresist
SG194570A1 (en)	2011-04-22	2013-12-30	Radius Health Inc	Method of drug delivery for pth, pthrp and related peptides
KR20150116468A (ko) *	2011-06-07	2015-10-15	아사히 가세이 파마 가부시키가이샤	고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
CA2857501C (en)	2011-11-30	2020-06-23	3M Innovative Properties Company	Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
HRP20251500T1 (hr)	2014-03-28	2026-01-02	Duke University	Liječenje raka dojke pozitivnog na receptor estrogena uporabom selektivnih modulatora receptora estrogena
EP4137147A3 (en) *	2015-03-03	2023-04-05	Radius Health, Inc.	Uses of abaloparatide in reducing fracture risk
SG10202104177VA (en)	2015-04-29	2021-05-28	Radius Pharmaceuticals Inc	Methods of treating cancer
CN108025042A (zh) *	2015-07-06	2018-05-11	董正欣	PTHrP类似物的新型制剂
KR101982103B1 (ko)	2015-08-31	2019-05-27	롬 앤드 하스 일렉트로닉 머트어리얼즈 엘엘씨	오버코팅된 포토레지스트와 함께 사용하기 위한 코팅 조성물
EP3909566A1 (en) *	2015-10-09	2021-11-17	Radius Health, Inc.	Formulations of pthrp analogues, transdermal patches thereof, and uses thereof
WO2017184355A1 (en)	2016-04-18	2017-10-26	Radius Health, Inc.	Formulations of abaloparatide, transdermal patches thereof, and uses thereof
ES2913470T3 (es)	2016-06-22	2022-06-02	Ellipses Pharma Ltd	Métodos de tratamiento de cáncer de mama AR+
JP7649624B2 (ja) *	2016-11-30	2025-03-21	パーデューリサーチファウンデーション	副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
AU2018205285C9 (en)	2017-01-05	2024-05-23	Radius Pharmaceuticals, Inc.	Polymorphic forms of RAD1901-2HCl
US10996208B2 (en)	2017-04-28	2021-05-04	Radius Health, Inc.	Abaloparatide formulations and methods of testing, storing, modifying, and using same
EP3765488A1 (en) *	2018-03-12	2021-01-20	Fresenius Kabi iPSUM S.r.l.	Process for the manufacture of pthrp analogue
WO2019232285A1 (en)	2018-05-30	2019-12-05	Purdue Research Foundation	Targeting anabolic drugs for accelerated fracture repair
WO2020010216A1 (en)	2018-07-04	2020-01-09	Radius Pharmaceuticals, Inc.	Polymorphic forms of rad 1901-2hcl
MA54946A (fr)	2019-02-12	2021-12-22	Radius Pharmaceuticals Inc	Procédés et composés
EP4110371A1 (en)	2020-01-24	2023-01-04	Radius Health, Inc.	Methods of stimulating bone growth with abalopartide and denosumab
WO2023281447A1 (en)	2021-07-07	2023-01-12	Radius Health, Inc.	Methods of treating a cardiovascular ischemic event

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5977070A (en)	1992-07-14	1999-11-02	Piazza; Christin Teresa	Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5821225A (en) *	1992-07-14	1998-10-13	Syntex (U.S.A.) Inc.	Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) *	1992-07-14	1996-12-31	Syntex (U.S.A.) Inc.	Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
EP0679088B1 (en)	1992-09-29	2002-07-10	Inhale Therapeutic Systems	Pulmonary delivery of active fragments of parathyroid hormone
WO1995002610A1 (en)	1993-07-13	1995-01-26	Syntex (U.S.A.) Inc.	Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5969095A (en) *	1995-07-13	1999-10-19	Biomeasure, Inc.	Analogs of parathyroid hormone
US5723577A (en)	1995-07-13	1998-03-03	Biomeasure Inc.	Analogs of parathyroid hormone
US5955574A (en) *	1995-07-13	1999-09-21	Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.	Analogs of parathyroid hormone
US6544949B1 (en) *	1995-07-13	2003-04-08	Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S.	Analogs of parathyroid hormone
US7410948B2 (en) *	1995-07-13	2008-08-12	Societe De Conseils De Recherches Et D'applications Scientifiques, Sas	Analogs of parathyroid hormone
CN1204262A (zh) *	1995-10-17	1999-01-06	曼海姆泊灵格股份公司	稳定的含甲状旁腺激素的药物给药剂型
TW505654B (en) *	1996-07-30	2002-10-11	Hoffmann La Roche	Synthesis of analogs of PTH and PTHrP
US6136784A (en) *	1997-01-08	2000-10-24	Amylin Pharmaceuticals, Inc.	Amylin agonist pharmaceutical compositions containing insulin
JP2002509854A (ja)	1997-09-09	2002-04-02	エフ．ホフマン−ラロシュアーゲー	ＰＴＨｒＰ類似体を使用する骨折治癒
US6770623B1 (en) *	1997-12-09	2004-08-03	Eli Lilly And Company	Stabilized teriparatide solutions
ZA9811127B (en)	1997-12-09	2000-07-11	Lilly Co Eli	Stabilized teriparatide solutions.
SE9801495D0 (sv)	1998-04-28	1998-04-28	Astra Ab	Protein formulationa
US6756480B2 (en)	2000-04-27	2004-06-29	Amgen Inc.	Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) *	2000-04-27	2005-06-09	Amgen Inc.	Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US7371721B2 (en) *	2000-09-18	2008-05-13	Sanos Bioscience A/S	Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7799757B2 (en) *	2002-06-13	2010-09-21	Michael Chorev	Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
CA2511966A1 (en)	2002-11-01	2004-07-22	Amgen Inc.	Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
TWI359026B (en) *	2004-02-12	2012-03-01	Sankyo Co	Pharmaceutical composition for the osteoclast rela
EP1750756A2 (en) *	2004-05-10	2007-02-14	Nastech Pharmaceutical Company Inc.	Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US7803770B2 (en)	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
DK2073789T3 (da)	2006-10-03	2019-08-05	Radius Health Inc	Stabil sammensætning omfattende et knogle-anabolisk protein, nemlig en pthrp-analog, og anvendelser deraf

2007
- 2007-10-03 DK DK07870768.4T patent/DK2073789T3/da active
- 2007-10-03 BR BRPI0719821A patent/BRPI0719821B8/pt active IP Right Grant
- 2007-10-03 PL PL15176548T patent/PL2957278T3/pl unknown
- 2007-10-03 EP EP15176548.4A patent/EP2957278B1/en not_active Revoked
- 2007-10-03 BR BRPI0722428-1A patent/BRPI0722428A2/pt not_active Application Discontinuation
- 2007-10-03 DK DK15176548.4T patent/DK2957278T3/en active
- 2007-10-03 RS RS20170803A patent/RS56164B1/sr unknown
- 2007-10-03 ES ES15176548.4T patent/ES2637283T3/es active Active
- 2007-10-03 CN CN201110220104.XA patent/CN102274492B/zh active Active
- 2007-10-03 WO PCT/US2007/021216 patent/WO2008063279A2/en not_active Ceased
- 2007-10-03 KR KR1020187030530A patent/KR20180117738A/ko not_active Ceased
- 2007-10-03 AU AU2007322334A patent/AU2007322334B2/en active Active
- 2007-10-03 SI SI200731956T patent/SI2957278T1/sl unknown
- 2007-10-03 MX MX2009003569A patent/MX2009003569A/es active IP Right Grant
- 2007-10-03 SG SG2011071784A patent/SG175580A1/en unknown
- 2007-10-03 KR KR20147033817A patent/KR20150020289A/ko not_active Ceased
- 2007-10-03 RU RU2009116531/15A patent/RU2506070C2/ru not_active IP Right Cessation
- 2007-10-03 KR KR1020177015557A patent/KR20170067906A/ko not_active Ceased
- 2007-10-03 CN CN2007800370219A patent/CN101578093B/zh active Active
- 2007-10-03 UA UAA200904264A patent/UA98776C2/ru unknown
- 2007-10-03 PT PT151765484T patent/PT2957278T/pt unknown
- 2007-10-03 LT LTEP15176548.4T patent/LT2957278T/lt unknown
- 2007-10-03 PT PT07870768T patent/PT2073789T/pt unknown
- 2007-10-03 KR KR1020097008736A patent/KR101512377B1/ko active Active
- 2007-10-03 CA CA2664734A patent/CA2664734C/en active Active
- 2007-10-03 JP JP2009531434A patent/JP5375611B2/ja active Active
- 2007-10-03 US US12/311,418 patent/US8148333B2/en active Active
- 2007-10-03 EP EP07870768.4A patent/EP2073789B8/en active Active
- 2007-10-03 NZ NZ576682A patent/NZ576682A/xx unknown
- 2007-10-03 ES ES07870768T patent/ES2739459T3/es active Active
- 2007-10-03 IL IL197926A patent/IL197926A/en active IP Right Grant
2009
- 2009-04-20 NO NO20091545A patent/NO344885B1/no unknown
2017
- 2017-08-08 HR HRP20171217TT patent/HRP20171217T1/hr unknown
- 2017-08-10 CY CY20171100860T patent/CY1119198T1/el unknown
2023
- 2023-06-05 FR FR23C1024C patent/FR23C1024I2/fr active Active
- 2023-06-05 LU LU00309C patent/LUC00309I2/en unknown
- 2023-06-09 NL NL301235C patent/NL301235I2/nl unknown

Also Published As

Publication number	Publication date
LT2957278T (lt)	2017-09-11
EP2957278A1 (en)	2015-12-23
RU2506070C2 (ru)	2014-02-10
NO344885B1 (no)	2020-06-15
BRPI0722428A2 (pt)	2013-11-26
AU2007322334A1 (en)	2008-05-29
EP2957278B1 (en)	2017-05-17
IL197926A (en)	2014-08-31
IL197926A0 (en)	2011-08-01
CN101578093A (zh)	2009-11-11
CY1119198T1 (el)	2018-02-14
ES2739459T3 (es)	2020-01-31
CN102274492A (zh)	2011-12-14
RU2009116531A (ru)	2010-11-10
KR20170067906A (ko)	2017-06-16
DK2073789T3 (da)	2019-08-05
CN102274492B (zh)	2014-11-26
JP5375611B2 (ja)	2013-12-25
PL2957278T3 (pl)	2017-10-31
CA2664734C (en)	2023-08-01
RS56164B1 (sr)	2017-11-30
EP2073789A2 (en)	2009-07-01
US20100029556A1 (en)	2010-02-04
KR101512377B1 (ko)	2015-04-28
JP2010505835A (ja)	2010-02-25
DK2957278T3 (en)	2017-07-31
EP2073789B8 (en)	2023-02-08
SI2957278T1 (sl)	2017-09-29
SG175580A1 (en)	2011-11-28
BRPI0719821B1 (pt)	2020-04-14
BRPI0719821B8 (pt)	2021-05-25
KR20180117738A (ko)	2018-10-29
CN101578093B (zh)	2011-09-14
ES2637283T3 (es)	2017-10-11
UA98776C2 (ru)	2012-06-25
WO2008063279A2 (en)	2008-05-29
KR20150020289A (ko)	2015-02-25
AU2007322334B2 (en)	2011-12-22
WO2008063279A3 (en)	2009-06-25
LUC00309I2 (nl)	2025-09-22
US8148333B2 (en)	2012-04-03
MX2009003569A (es)	2009-08-25
KR20090083350A (ko)	2009-08-03
EP2073789B1 (en)	2019-05-22
WO2008063279A9 (en)	2008-07-10
PT2073789T (pt)	2019-07-31
PT2957278T (pt)	2017-08-23
FR23C1024I1 (fr)	2023-07-21
HRP20171217T1 (hr)	2017-10-20
FR23C1024I2 (fr)	2024-06-14
NZ576682A (en)	2012-08-31
BRPI0719821A2 (pt)	2013-05-07
NO20091545L (no)	2009-05-27
CA2664734A1 (en)	2008-05-29
HK1214181A1 (en)	2016-07-22

Publication	Publication Date	Title
NL301235I2 (nl)	2023-08-31	abaloparatide
DE602007013937D1 (de)	2011-05-26	Torantagonisten
AT504580A3 (de)	2008-07-15	Scan-einrichtung
EP2077271A4 (en)	2010-09-15	Macrolide derivative
DE602007008400D1 (de)	2010-09-23	Kaliummonopersulfatlösungen
DE502007001629D1 (de)	2009-11-12	Rfahren
ATE546437T1 (de)	2012-03-15	Aminomethyl-4-imidazole
DE502007000218D1 (de)	2008-12-18	nsetzungen
DE502007002453D1 (de)	2010-02-11	Kunstoffverdichtergehäuse
DE502007000361D1 (de)	2009-02-26	Stanznieteinheit
DE112007003147A5 (de)	2009-09-24	Rohr-Biegevorrichtung
DE602006016174D1 (de)	2010-09-23	Blisterverpackungsverfahren
BRPI0719956A2 (pt)	2014-04-29	Radiofluoração
FI20060691A0 (fi)	2006-07-19	Laitekotelointi
ITPD20060387A1 (it)	2008-04-20	Espositore
DE102006045567A8 (de)	2008-09-11	Crimpstabilisierung
FI7587U1 (fi)	2007-08-09	Vetovoimamittalaite
DE112007001125A5 (de)	2009-02-05	Käfigmutter
FI20065256A0 (fi)	2006-04-21	Lävistyspuristin
DE602006013286D1 (de)	2010-05-12	Sicherheitseinrictung
NO20060756L (no)	2007-08-17	Transportsystem
DE502007001094D1 (de)	2009-09-03	Hubkupplung
FI20065768A0 (sv)	2006-12-01	Eldstd
ITRM20060031A1 (it)	2007-07-25	Elettroconduttura
FI7640U1 (fi)	2007-10-22	Jätesäkinpidike